Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance from the FDA. The company’s Hb 801 system allows healthcare ...
HemoCue AB report fruitful discussions, continued support and new activities related to health initiatives, following the participation at the High-Level Business Delegation in New Delhi and Mumbai, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback